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The evidence for effects of the retinoids on UV -induced 
carcinogenesis is sparse. Clinical observations indicate 
that topical RA can cause significant regression of pre-
malignant actinic keratoses. Also there is some evidence 
that this agent can cause dissolution of some basal cell 
epitheliomas. However this latter effect does not appear 
to be of therapeutic value. Systemic retinoids are oflittle 
value in the treatment of premalignant and malignant 
cutaneous lesions though 13-cis-retinoic acid might be of 
use in the basal cell nevus syndrome. Examination of the 
influence of the retinoids on photocarcinogenesis essen-
tially has been confined to RA and animal experimenta-
tion. RA in nontoxic concentrations can both stimulate 
and inhibit photocarcinogenesis depending upon the cir-
cumstances of the study. The mechanisms of these re-
sponses are not clear. Influences on DNA synthesis di-
rectly and/or indirectly or on immune responses may be 
involved in both effects. Preliminary studies with oral 
13-cis-retinoic acid have not demonstrated any effects to 
date on UV -induced skin cancer formation_ 
The retinoids comprise. a set of molecules consisting of vi-
tamin A and its synthetic analogs, several of which have inhib-
itory effects on cancer formation. However experience concern-
ing these agents and ultraviolet (UV) carcinogenesis has been 
confined almost entirely to all-trans retinoic acid (RA) or tre-
tinoin . This is a biologically active analog of vitamin A that has 
demonstrated antineoplastic properties on certain experimen-
tally induced and naturally occurring tumors [1-6]. Therefore 
the bulk of this review will be concerned with the effects of this 
retinoid. 
CLINICAL OBSERVATIONS 
Topical Applications 
The sun is the primary stimulus for the vast majority of 
premalignant and malignant tumors that occur in the skin. 
Actinic keratoses are by far the most common precancerous 
growths. In 1962 Stiittgen reported regression of such lesions 
by topical app lications of RA [5]. Several studies have con-
firm ed these findings. Bollag and Ott [7], using high concentra-
tions (0.1 and 0.3%) in an ointment base, reported complete 
regression in 24 and 50% regression in 20 of 51 patients with 
multiple actinic keratoses of the face. In the remaining 7 pa-
tients no effect was noted. In addition, actinic keratoses on the 
hands and forearms did not respond as well as those on the 
face. Subsequently Schumacher and Stuttgen [3J, Robinson 
and Kligman [8] and Barranco, Olson, and Everett [9] con-
firmed these beneficial effects on facial keratoses. Robinson and 
Kligman [8] also noted that the RA was. much less effective on 
forearm and hand )esions. However they noted that combina-
·tion therapy with 5-fluorouracil was much more effective than 
either chemical alone on these upper extremity keratoses. 
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The most common human skin malignancy is the basal cell 
epithelioma. In most instances sun exposure is at least partially 
responsible for these tumors though other factors appear to 
playa role. Bollag and Ott reported full clinical remission in 5 
and partial clearing in 10 of 16 patients [7]; 1 did not respond 
at all. Schumacher and Stuttgen also noted regression of some 
lesions [3]. However Remy and Stiittgen noted remnants of 
these growths histologically if they were not superficial in 
nature [10]. 
Systemic Administration 
There are a few reports which suggest that large doses of 
vitamin A orally will cause regression of actinic keratoses and 
basal epitheliomas ell]. However it has not been of significant 
value in the therapy of such lesions. More recently Peck et al 
reported beneficial therapeutic effects of 13-cis-retinoic acid on 
basal cell epitheliomas in several cases [12]. 
Summary 
There is definitive evidence that topical RA can cause regres-
sion of sun-induced premalignant lesions and may be effective 
therapeutically. It appears to be of little value as an appropriate 
treatment for skin cancers. The oral administration of the 
retinoids has also proven to be of little value in the treatment 
of premalignant and malignant cutaneous lesions though 13-cis-
retinoic acid might be considered for use in the basal cell nevus 
syndrome. 
EXPERIMENTAL STUDIES 
As noted, the clinical observations indicate that the retinoids, 
primarily RA, may be of value in the treatment of premalignant 
actinic keratoses. However the influence of these molecules on 
the development of UV -induced cancers has been confmed to 
animal experimentation. At the outset it should be emphasized 
that no clinical or experimental evidence has indicated that 
these molecules produce cancers by themselves. There is infor-
mation concerning their effects on experimentally induced pho-
tocarcinogenesis. 
In the initial study of this problem a 0.3% concentration of 
RA was used in a cream base (obtained fro m Hoffman-LaRoche 
Inc., Nutley, N.J.) [13]. The animals were divided into 2 groups. 
The right flanks of the mice in group I were exposed to l.38 X 
103 mJ/cm2 of UV energy from a hot quartz contact source 3 
times a week for 10 mo. The retinoic acid cream (approximately 
0.5 gm) was applied with a wooden applicator to the right and 
left flanks of each mouse inm1ediateiy after UV exposure for 
the first 41/2 mo. The mice in group II received UV exposures as 
in group I but the cream base was used in place of the retinoic 
acid applications for the first 4 V2 mo. 
Within the flrst 3 to 4 weeks all of the mice in group I 
developed erythema and desquamation which continued 
throughout the study but subsided to some extent after discon-
tinuing the retinoic acid applications. Thirteen of these mice 
died by 41/2 mo necessitating discontinuance of t he topical 
applications. The cream base itself caused no observable cuta- . 
neous or systemic changes in the animals. No tumors occulTed 
on the unirradiated left flank skin in any of the mice, indicating 
that neither the cream base nor the retinoic acid was carcino-
genic under the circumstances of the study. 
The onset of tumors greater than 4 mm:] occurred by about 
6 mo in both groups. However, they appeared more rapidly in 
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group I up until 34 weeks at which time approximately equal 
numbers of mice were involved in both groups. Tumors greater 
t han 50 mm3 appeared earlier and were more prevalent in mice 
treated with retinoic acid up until 35 weeks. Thereafter, there 
was no significant difference in comparative tumor incidence 
between the placebo and retinoic acid-treated animals. The 
tumors in both groups were invasive growths which enlarged 
progressively a nd eventually became greater than 100 mm'l. 
(Eight-five percent of the tumor-bearing mice in group I and 
86% of those in group II had bound-down tumors greater than 
100 mm:]). These results indicate that topical applications of 
retinoic acid promoted UV -induced cancer formation under the 
circumstances of this study. The experimental animals were 
Uscd strain albino hairless mice . 
The concentration of RA used in this study was similar to 
that used for treatment of human actinic keratoses and basal 
cell epitheliomas. However it was qui te irrita ting and toxic to 
t h e hairless mouse. 
Subsequently Forbes, Urbach, and Davies examined this 
problem using low, essent ially nonirritating and nontoxic, con-
centrations of RA [14]. In this study they used the Skh hairless 
mouse which is similar, if not ident ical , to the Uscd mouse. The 
radiation source was a solar simulator and 0.01 and 0.001 % 
concentrations of RA in methanol were used. The mice were 
divided into 6 groups and tr eated as fo llows: Group A was 
treated with methanol and irradiated 7 days a week for 30 
weeks; group B received 0.001 % RA and UV; group C received 
0.01 % RA and UV; group D received 0.1 % croton oil and UV; 
group E received methanol; and group F received 0.01 % RA. As 
noted in Table I, both RA concentrations significantly acceler-
ated the UV-induced tumor formation. Thus it is clear that RA 
in nontoxic and essent ially nonirri tating concentrations can 
stimulate photocarcinogenesis. 
While Forbes, Urbach, and Davies were completing the above 
mentioned study we were also examining the effects of lower, 
nonirritating concentrations of RA on photocarcinogenesis in 
our system [15]. Again the Uscd hairless mouse and the hot 
quartz radiation sow'ce were used. The mice were t reated as 
follows: All of the mice received 1.25 mJ /cm2 of UVB to the 
posterior half of their backs 3 times a week for the duration of 
t he study. Group 1 was treated with 0.05% appHcations to the 
w hole back following the UV exposures. Group 2 received 
0.025% RA applications; group 3 received 0.005% RA applica-
tions and group 4, diluent applications and UV as in group 1. 
Tumors greater than 4, 50, and 100 mm" were tabulated at 
weekly intervals. All tumors greater than 50 mm:J were squa-
mous cell carcinomas. No tumors were produced by the RA or 
diluent applications alone. 
The results for all 3 tumor sizes were essentially identical in 
t h e irradiated areas and are demonstrated in the graph for 100 
mmJ tumors. As noted, the onset of the tumors occurred at 
TABLE I. Prevalence of skin tumors (>1 mm) at selected t ime 
p eriods 
Weeks 
Group Treatment 
35 40 50 55 
A Methanol + 0/ 0/52 1/ 1/5 1 12/ 12/ 51 27/23/ 5 1 
UVR 
B 0.00 1% RA + 92/ 34/54 145/ 40/ 54 210/39/4 1 202/ 33/ 33 
UVH 
C 0. 1% RA + UVR 108/ 31/ 49 156/ 38/ 49 171/ 38/ 39 310/ 31/ 33 
0 0.1% Croton Oil 7/ 6/ 51 11 / 9/ 5 1 30/ 16/ 48 41/ 22/ 46 
+ UVR 
E Methanol Dilly 0/ 0/ 55 Ol D/ 51 0/ 0/ 49 0/ 0/ 49 
F 0.0 1% HA only 1/ 1/48 1/ 1/ 48 1/ 1/ 44 1/ 1/ 44 
Tumors/ number of affected animals/ survi vor at se lected intervals after s tart 
of trea tment. S tarting size of groups was 60 (30 males and 30 females); U"eatmen( 
with HA was da ily for 30 weeks. UVH was given daily for 28 weeks, sta rting 2 
weeks afte r in it iation of HA application. Croton oil was appli ed fo r 28 weeks, 
concurrent with UVR treatme nt. (From reference 14, is published with th e 
permission of D rs. Forbes, Urbach, and O;tv ies and Else vier( North- Holland 
Scientific Publishers, Ltd.). 
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approximately the same time in all 4 groups. Also, the devel-
opment of t umors throughout the study was not significantly 
different in groups 2, 3, and 4. By the end of the study almost 
all of the mice in these 3 groups had developed cancers, indi-
cating that a carcinogenic amoun t of UV had been adminis-
tered. In contrast, tumors developed significantly slower and 
the t umor incidence was significantly lower in mice treated with 
t he 0.05% RA applications. 
Two subsequent studies were reported at a recent workshop 
on retinoic acid and photocarcinogenesis [16]. Davies and his 
co-workers reported on a 2 stage type of study in which the 
Skh mice received UVB irradiation from FS 40 sunlamps for 6 
weeks fo llowed by 0.01 % RA or croton oil applications 3 times 
a week for 14 weeks. Both chemicals accelerated the photocru'-
cinogenesis but the effect was much more notable in RA-treated 
animals. The diluent had no observable effect. 
In the second study Kligman, using the hairless mouse model, 
FS sunlamp exposures and 0.001 a nd 0.01% concentrations of 
RA, could detect no influence of the chemical on the tumor 
development pattern. However since all of the mice developed 
tumors by 30 weeks it seems most likely the lack of detectable 
effect was due to the use of too much radiation. 
At present there is little information on the effects of systemic 
retinoids on photocal'cinogenesi . However we ar e in the process 
of examining the effects of oral 13-cis-retinoic acid in the Uscd 
hairless mouse system using the hot quar tz source. The mice 
a re irradiated 3 times a week and receive 10 mg/ kg of the 
chemical orally 5 times a week. The development of tumors 
greater than 4, 50, and 100 mm;) has followed essent ially the 
same patterns to date as expressed in Table II. As noted, by 34 
weeks no significant effect of the chemical has been detected 
under the cir cumstances of this study. 
Be that as it may, it has been established that RA can both 
accelerate and inhibit photocarcinogenesis under appropriate 
conditions. The mecha nism or mechanisms involved in either 
effect are not cleru·. 
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T his graph demonstrates t h e cummulative probability of the d evel-
opm e n t of tumors in the 4 g roups noted in t his study calculated from 
t h e li fe-tab le a na ly is presen ted in re fe re nce 15. 
TABLE I!. P ercen l of mice with. lumors grea ler Ilion 50 mm" 01 Ihe 
noled lime p eriods 
13 cis HA" Control 
24 wk 9% 13% 
29 wk 13% 23% 
34 w k 42% 39% 
" T hese m ice rece ive d 10 mg/ kg of 13-cis -re t inoic ac id ora lly 5 days 
a week. 
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Stimulation of UV carcinogenesis might be related to effects 
on DNA metabolism and induction of epidermal proliferation 
[17], or immunosuppression which has been demonstrated with 
high doses of RA [18]. Unfortunately there is very li ttle data 
available at this time which might explain this demonstrated 
accelerating effect of RA on photocarcinogenesis. 
In contrast, there are a number of studies describing RA 
effects which might be responsible for the inhibitory response 
notes. In a recent study we noted that though repeated appli-
cations of RA over a 10- and 23-week period caused epidermal 
acanthosis, they blunted the response of the skin to acute UV 
injury [17]. Thus the expected increase in DNA synthesis and 
hyperplastic response which occurs by 24 hr post-UV irradia-
tion was significantly suppressed. 
Such an inhibition effect on DNA synthesis could be me-
diated through blocking the induction of ornithine decarboxyl-
ase (ODC) which is the rate limiting enzyme in the polyamine 
pathway. The potent che'mical tumor promoter 12-0-tetrade-
canoyl-phorbol-13-acetate (TPA) induces ODC activity which 
is directly correla ted with its tumor promoting activities [19]. 
UV energy also stimulates epidel'mal ODC activity [22,23] and 
inhibition of this enzymatic response by RA has been noted 
under certain circumstances [16]. 
Topical RA has also been shown to inhibit DNA synthesis in 
psoriatic epidermis [24] and MCA-induced DNA synthesis and 
hyperplasia in prostate organ culture [25]. Iversen has also 
noted that RA inhibited UV-induced endogenous dehydrogen-
ase activity in the epidermis as measured by the tetrazolium-
reduction method [16]. Increased dehydrogenase activity has 
been noted after exposure to ionizing radiation and chemical 
carcinogens but not noncarcinogenic cutaneous irritants. This 
technique forms the basis for the tetrazolium test for skin 
carcinogenesis [26]. 
Other . possible mechanisms reported include inhibition 
through control of cell differentiation [4,27], enhancement of 
cell mediated cytotoxicity [28], perhaps through killer T-cell 
stimulation [29] , labilizing lysosomal membranes [30], and in-
hibition of the transforming effects of endogenous growth fac-
tors [31]. . 
Whether one, combinations of several, or none of these mech-
anisms relate to the inhibition of UV carcinogenesis noted in 
this study remains to be determined. 
Summary 
Examination of the influence of retinoids on photocarcino-
genesis essentially has been confined to RA and animal exper-
ime nt~tion . These studies have established that RA in nontoxic 
concentrations can both stimulate and inhibit photocarcinoge-
nesis depending upon the circumstances of the investigations. 
The mechanisms of either response are not clear. Influence on 
DNA synthesis directly and/or indirectly or on immune re-
sponses may be involved in either. or both effects. 
Preliminary studies with oral 13-cis-retinoic acid have not 
demonstrated any effects on UV -induced skin cancer formation 
.as yet. 
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